title: New dimensions in Hirsutism.
abstract: The following is a review of a satellite symposium held at the British Medical Laser Association Meeting, in November 2005. Prof. V.A. Randall gave a comprehensive overview of hormones and hair growth, followed by an in-depth discussion of hirsutism, the therapeutic options, treatment and trends, by Dr. S. Lanigan. Dr. I. Hamzavi concluded the symposium with a presentation of the latest work on eflornithine in combination with laser hair removal. Data were reproduced with the speakers' permission.
authors.affiliation: Department of Biomedical Sciences, University of Bradford, Bradford, B7 1DP, UK. V.A.Randall@Bradford.ac.uk
authors.forename: V A
authors.initials: VA
authors.lastname: Randall
authors.forename: S
authors.initials: S
authors.lastname: Lanigan
authors.forename: I
authors.initials: I
authors.lastname: Hamzavi
authors.forename: L
authors.initials: L
authors.lastname: Chamberlain James
mesh_terms: D000728:Androgens / Q000378:metabolism; D042944:Cholestenone 5 alpha-Reductase / Q000378:metabolism; D000518:Eflornithine / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D028022:Low-Level Light Therapy / Q000009:adverse effects; D008297:Male; D012727:Sex Characteristics; D012737:Sex Factors; D013739:Testosterone / Q000378:metabolism
chemical_list: D000728:Androgens; D004791:Enzyme Inhibitors; D013739:Testosterone; D042944:Cholestenone 5 alpha-Reductase; D000518:Eflornithine